News

GlaxoSmithKline (GSK) today announced that the FDA has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine. The approval of the sBLA,

Belgium’s regulatory agency, the AFMPS has approved NextPharma Technologies’ new Sterile Product Development Centre (SPDC) in Braine l’Alleud. NextPharma had signed its first contract in April and will

DotCode, a rectangular matrix symbology, was published by AIM, the international association focusing on bar codes, RFID and enterprise mobile computing. Reportedly, the DotCode is suitable for machine-readable

InVitria has expanded its manufacturing capacity to meet commercial demands for Lysobac. Lysobac is an animal free reagent for bacterial fermentation. InVitria claims, Lysobac is a high potency,

Carton Service’s division Carton Service-Packaging Insights has changed its name to Pharma Packaging Solutions. The company said that the new name is a result of customer inputs and

Ortho Kinematics develops The KineGraph VMA (Vertebral Motion Analyzer), a new functional diagnostic test for the spine that uses fluoroscopy to capture the spine in motion.

Quay Pharmaceuticals has announced that it will relocate Wirral to North Wales to new headquarters and manufacturing facility. The transaction is expected to cost £2.7m. Quay Pharmaceuticals’ new

Amarillo Biosciences (ABI) has reported that a Phase 2 clinical trial of ABI’s low-dose oral interferon is ongoing in Australia in 200 healthy human volunteers exposed to the